Physician profile
Marjorie N Harvill-Brooks
NPI 1831148196
$52,940.25
in general payments reported to CMS, 2019-2025
11 companies · $21K in 2025
The $21K reported for 2025 was more than what 97% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $747 · 2020: $432 · 2021: $1,141 · 2022: $11K · 2023: $9,020 · 2024: $9,126 · 2025: $21K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Travel and Lodging: $5,743 · Food and Beverage: $4,406.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,995.00 |
| Travel and Lodging | $5,742.96 |
| Food and Beverage | $4,406.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $50,532.44 | 2019-2025 | Altis, Saffron, Restorelle |
| Bluewind Medical | $882.24 | 2024-2025 | Revi |
| Medtronic, INC. | $542.46 | 2021-2023 | Interstim |
| Caldera Medical, INC | $464.56 | 2020-2023 | Desara |
| Medtronic USA, INC. | $148.68 | 2020 | |
| Glaxosmithkline, LLC. | $125.00 | 2024 | Jemperli |
| Axonics, INC. | $93.24 | 2024 | Bulkamid, Axonics |
| Abbvie INC. | $48.42 | 2025 | |
| Coopersurgical, INC. | $39.47 | 2019-2023 | Advincula Delineator Uterine Manipulator |
| Intuitive Surgical, INC. | $32.31 | 2020 | |
| Ethicon US, LLC | $31.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Harvill-Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.